This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Novartis AG (NVS)

NYSE: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 50.39B 53.63B 58.83B 57.56B
Cost of Sales 17.40B 17.34B 19.61B 18.76B
Gross Operating Profit 32.98B 36.29B 39.22B 38.80B
Selling, General, and Administrative Expenses 17.12B 17.50B 19.83B 19.15B
Research & Development 8.94B 9.09B 9.85B 9.33B
Operating Income before D & A (EBITDA) 6.93B 9.70B 9.54B 10.32B
Depreciation & Amortization 0.00 0.00 0.00 0.00
Interest Income 33.00M 0.00 0.00 0.00
Other Income - Net 1.58B 1.36B 1.27B 1.09B
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 8.80B 12.98B 11.42B 11.97B
Interest Expense 669.00M 704.00M 683.00M 724.00M
Pre-Tax Income 8.13B 12.27B 10.73B 11.24B
Income Taxes 1.11B 1.54B 1.44B 1.62B
Minority Interest 11.00M 70.00M 117.00M 113.00M
Net Income From Continuing Operations 7.03B 10.73B 9.29B 9.62B
Net Income From Discontinued Operations 10.77B -447.00M 0.00 0.00
Net Income From Total Operations 17.79B 10.28B 9.29B 9.62B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 17.78B 10.21B 9.18B 9.51B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
7.03B 10.73B 9.29B 9.62B
Preferred Dividends
Net Income Available To Common 7.03B 10.73B 9.29B 9.62B
Basic EPS from Continuing Ops. 2.92 4.39 3.76 3.93
Basic EPS from Discontinued Ops. 4.48 -0.18 0.00 0.00
Basic EPS from Total Operations 7.40 4.21 3.76 3.93
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 7.40 4.21 3.76 3.93
Basic Normalized Net Income/Share 2.92 4.39 3.76 3.93
EPS fr Continuing Ops. 2.88 4.31 3.70 3.89
EPS fr Discontinued Ops 4.41 -0.18 0.00 0.00
EPS fr Total Ops. 7.29 4.13 3.70 3.89
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 7.29 4.13 3.70 3.89
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.88 4.31 3.70 3.89
Dividends Paid per Share 2.67 10.09 2.53 2.48
NVS News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for NVS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 6 6
Moderate Buy 0 0 0 0
Hold 2 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET NVS ANALYST REPORT

NVS Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs